Assertion: monoclonal antibody | /r/CapableOf | continue to be the benchmark
Facets:
Source sentences:
text: therapies revolutionized the treatment of B cell malignancies and autoimmune disorders, starting with the monoclonal antibody (mAb) rituximab (RTX; Rituxan), which was the first approved therapeutic mAb for cancer and continues to be the benchmark for second- and third-generation mAbs (1, 12).